PharmaLeaders.com

News. Resources. Community.

  • Features
  • Channels
    • Biotech Channel
    • Clinical Channel
    • CME Channel
    • Compliance Channel
    • Device Channel
    • HIMSS Channel
    • Marketing Channel
    • Pharma Channel
    • R&D Channel
    • Telehealth Channel
    • Training Channel
  • Events
  • On Demand
  • White Papers
  • Vendors
    • Biotech Vendors
    • Clinical Vendors
    • CME Vendors
    • Compliance Vendors
    • Device Vendors
    • Marketing Vendors
    • Pharma Vendors
    • R&D Vendors
    • Training Vendors
  • Contributors

Mental Health: An Insurance Industry Perspective

04/26/2017 by Jim Miller

How payers look at priorities for care in a time of policy uncertainty and growing concerns in the patient advocacy community.

No group of stakeholders wields greater influence over patient access to medicines than payers making reimbursement and formulary decisions. Even in a time of policy upheaval in Washington, health plans must make sure members get the medicines they need. Insurers say they’re committed to this role when it comes to mental health conditions, which affect one in five American adults. And they say their commitment won’t change regardless of how the policy landscape may shift in Washington.

Download White Paper

Filed Under: Marketing Channel White Papers

  • Facebook
  • LinkedIn
  • Twitter

Choose Your Channel

Receive event announcements and special reports directly in your inbox.
  • This field is for validation purposes and should be left unchanged.

Upcoming Events

  1. 6th CAR-TCR Summit Europe

    February 21 - February 23
  2. 7th Virtual Clinical Trials Summit

    May 16 - May 17

View All Events

  • About Us
  • Sponsorship
  • Join Our Team
  • Contact Us

Copyright © 2023 PharmaLeaders.com. All rights reserved.